S Florman

Summary

Affiliation: Tulane University
Country: USA

Publications

  1. pmc Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon
    Sidhartha Hazari
    Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, USA
    Virol J 4:89. 2007
  2. ncbi request reprint Liver transplantation for neuroendocrine tumors
    Sander Florman
    Recanati Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, New York, USA
    J Gastrointest Surg 8:208-12. 2004
  3. ncbi request reprint The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation
    Sander Florman
    The Recanti Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, USA
    Clin Transplant 18:152-5. 2004
  4. ncbi request reprint Unresectable squamous cell carcinoma of donor origin treated with immunosuppression withdrawal and liver retransplantation
    Sander Florman
    The Recanati Miller Transplantation Institute, New York, NY, USA
    Am J Transplant 4:278-82. 2004
  5. ncbi request reprint Efficacy of double gloving with an intrinsic indicator system
    Sander Florman
    Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA
    Surg Infect (Larchmt) 6:385-95. 2005
  6. ncbi request reprint Live donor liver transplantation
    Sander Florman
    Tulane University School of Medicine, Tulane University Hospital and Clinic, New Orleans, LA 70112, USA
    Liver Transpl 12:499-510. 2006
  7. ncbi request reprint Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen
    S Florman
    Tulane University, New Oreleans, Louisiana 70112, USA
    Transplant Proc 37:1211-3. 2005
  8. ncbi request reprint Aggressive resection of hepatocellular carcinoma with right atrial involvement
    Sander Florman
    Department of Surgery, Tulane University, New Orleans, Louisiana, USA
    Am Surg 75:1104-8. 2009
  9. ncbi request reprint Long-term outcome of single pediatric donor kidney transplants between African-American and non-African-American adults
    A Paramesh
    Departments of Surgery, School of Medicine, Tulane University, New Orleans, LA, USA
    Clin Nephrol 72:55-61. 2009
  10. ncbi request reprint Improved results in small bowel transplantation using sirolimus
    S Florman
    Recanti Miller Transplantation Institute, The Mount Sinai Medical Center, New York, New York 10029, USA
    Transplant Proc 34:936. 2002

Collaborators

Detail Information

Publications35

  1. pmc Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon
    Sidhartha Hazari
    Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, USA
    Virol J 4:89. 2007
    ..The mechanisms of IFN-resistance are unclear. The aim of this study was to determine the contribution of host cell factors to the mechanisms of interferon resistance using replicon cell lines...
  2. ncbi request reprint Liver transplantation for neuroendocrine tumors
    Sander Florman
    Recanati Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, New York, USA
    J Gastrointest Surg 8:208-12. 2004
    ..Of the three patients surviving more than 5 years, only one was disease free. In carefully selected patients with metastatic NETs, liver transplantation may be an appropriate option...
  3. ncbi request reprint The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation
    Sander Florman
    The Recanti Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, USA
    Clin Transplant 18:152-5. 2004
    ..4% while for patients without late ACR (n = 488) it is 82.0% (p = ns). Patients remain at risk for ACR even after 1000 d post-transplant, particularly those with PSC...
  4. ncbi request reprint Unresectable squamous cell carcinoma of donor origin treated with immunosuppression withdrawal and liver retransplantation
    Sander Florman
    The Recanati Miller Transplantation Institute, New York, NY, USA
    Am J Transplant 4:278-82. 2004
    ..More than 2 years later she remains disease-free with complete pathological remission. This is the only reported case of squamous cell carcinoma of donor origin arising in a transplanted liver...
  5. ncbi request reprint Efficacy of double gloving with an intrinsic indicator system
    Sander Florman
    Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA
    Surg Infect (Larchmt) 6:385-95. 2005
    ....
  6. ncbi request reprint Live donor liver transplantation
    Sander Florman
    Tulane University School of Medicine, Tulane University Hospital and Clinic, New Orleans, LA 70112, USA
    Liver Transpl 12:499-510. 2006
    ..Transplant physicians, particularly surgeons, must take responsibility for regulating and overseeing these procedures...
  7. ncbi request reprint Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen
    S Florman
    Tulane University, New Oreleans, Louisiana 70112, USA
    Transplant Proc 37:1211-3. 2005
    ..The purpose of this pharmacokinetic (PK) study was to evaluate tacrolimus exposure in stable liver transplant recipients converted from Prograf twice a day to MR tacrolimus once daily...
  8. ncbi request reprint Aggressive resection of hepatocellular carcinoma with right atrial involvement
    Sander Florman
    Department of Surgery, Tulane University, New Orleans, Louisiana, USA
    Am Surg 75:1104-8. 2009
    ..We report an exceptional case of a patient with such a tumor successfully treated with an aggressive surgical approach and review the limited published experience...
  9. ncbi request reprint Long-term outcome of single pediatric donor kidney transplants between African-American and non-African-American adults
    A Paramesh
    Departments of Surgery, School of Medicine, Tulane University, New Orleans, LA, USA
    Clin Nephrol 72:55-61. 2009
    ..African-American (AA) ethnicity has been considered a risk factor for graft loss after kidney transplant. The long-term graft survival of single pediatric donor kidney transplants in AA adults has not been reported...
  10. ncbi request reprint Improved results in small bowel transplantation using sirolimus
    S Florman
    Recanti Miller Transplantation Institute, The Mount Sinai Medical Center, New York, New York 10029, USA
    Transplant Proc 34:936. 2002
  11. pmc One hundred nine living donor liver transplants in adults and children: a single-center experience
    C M Miller
    Recanati Miller Transplantation Institute, Mount Sinai Hospital, Mount Sinai School of Medicine, New York, New York 10029, USA
    Ann Surg 234:301-11; discussion 311-2. 2001
    ..To summarize the evolution of a living donor liver transplant program and the authors' experience with 109 cases...
  12. doi request reprint Donor and recipient factors predicting time to graft failure following orthotopic liver transplantation: a transplant risk index
    A M Stey
    Department of Surgery, Mount Sinai Medical Center, New York, New York, USA
    Transplant Proc 45:2077-82. 2013
    ..Much of the success of a transplant depends on appropriate matching of donor to recipient...
  13. ncbi request reprint Cytomegalovirus matching does not predict symptomatic disease in intestinal transplantation
    M Burroughs
    Department of Pediatric Infectious Diseases, Mount Sinai School of Medicine, New York, New York 10029, USA
    Transplant Proc 34:946-7. 2002
  14. doi request reprint Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients
    N Kerkar
    Department of Surgery, Recanati Miller Transplant Institute, The Mount Sinai School of Medicine, New York, NY 10029, USA
    Clin Transplant 25:E584-91. 2011
    ..First-line therapy with anti-lymphocyte preparations, prophylactic anti-microbial therapy, and close monitoring allow excellent rates of patient and graft survival...
  15. ncbi request reprint Identification of ultrastructural changes in liver allografts of patients experiencing primary nonfunction
    A Lawal
    Department of Liver Diseases and Transplantation, The Mount Sinai Medical Center, New York, New York 10029, USA
    Transplant Proc 37:4339-42. 2005
    ..Using electron microscopy, we examined the hepatic ultrastructure of donor allografts in patients experiencing PNF and compared the findings with a well-matched group of other donor allografts...
  16. ncbi request reprint Noninvasive preoperative evaluation of biliary anatomy in right-lobe living donors with mangafodipir trisodium-enhanced MR cholangiography
    J Goldman
    Department of Radiology, Mount Sinai Hospital, New York, New York 10029, USA
    Transplant Proc 35:1421-2. 2003
    ..Volumetric magnetic resonance cholangiography (MRCP) using Mangafodipir trisodium (Mn-DPDP) contrast has been recently proposed to evaluate the biliary anatomy of living donor candidates...
  17. ncbi request reprint Clinical presentations of soft-tissue infections and surgical site infections
    R L Nichols
    Tulane University School of Medicine, Dept of Surgery, New Orleans, LA 70112 2699, USA
    Clin Infect Dis 33:S84-93. 2001
    ..Involvement of antibiotic-resistant gram-positive microorganisms in these infections only increases the difficulty of their treatment and may have a significant influence on the ultimate outcome...
  18. ncbi request reprint Utility of CT angiography for evaluation of living kidney donors
    D P Slakey
    Tulane Multi Organ Transplant Center, New Orleans, LA, USA
    Clin Transplant 13:104-7. 1999
    ..We believe that CT angiography is the radiologic procedure of choice for the assessment of renal anatomy in potential living kidney donors...
  19. ncbi request reprint Association of intraoperative blood pressure instability with adverse outcomes after liver transplantation
    S De Maria
    Department of Anesthesiology, The Mount Sinai Medical Center, New York, NY 10029, USA
    Minerva Anestesiol 79:604-16. 2013
    ..While this concept is often believed to be true, few have rigorously demonstrated the validity of this claim, especially in likely vulnerable OLT patients...
  20. ncbi request reprint A comparison of long-term survivals of simultaneous pancreas-kidney transplant between African American and Caucasian recipients with basiliximab induction therapy
    R Zhang
    Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA
    Am J Transplant 7:1815-21. 2007
    ..AA may not have worse long-term outcomes than CA recipients of SPK with basiliximab induction and tacrolimus (TAC), mycophenolate acid (MFA) and steroid maintenance immunotherapy...
  21. ncbi request reprint Graft function and survival depend primarily on host factors in compromised recipient models of orthotopic liver transplantation in the rat
    L Wang
    The Recanati/Miller Transplantation Institut, The Mount Sinai School of Medicine, New York, NY 10029, USA
    Transplantation 71:14-20. 2001
    ..CONCLUSION: These results suggest that preoperative status and different host factors have a significant effect on outcome and graft function after liver transplantation in rats...
  22. ncbi request reprint Intestinal and multiorgan transplantation: the Mount Sinai experience
    T Fishbein
    The Recanati Miller Transplantation Institute, The Mount Sinai Medical Center, New York, New York 10029, USA
    Transplant Proc 34:891-2. 2002
  23. ncbi request reprint Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients: a viewpoint by Sander Florman
    Sander Florman
    Department of Surgery, Tulane School of Medicine, New Orleans, Louisiana, USA
    Drugs 67:1944. 2007
  24. ncbi request reprint Fulminant recurrence of atypical hemolytic uremic syndrome during a calcineurin inhibitor-free immunosuppression regimen
    Sander Florman
    The Recanati Miller Transplantation Institute and Department of Pediatric Nephrology, The Mount Sinai School of Medicine, New York, New York, USA
    Pediatr Transplant 6:352-5. 2002
    ..Avoidance of calcineurin inhibitors did not prevent recurrence of severe HUS and graft loss. Transplantation for severe atypical HUS remains problematic...
  25. ncbi request reprint Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease
    Anil S Paramesh
    The Recanat Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    Clin Transplant 18:94-9. 2004
    ..The aim of this study was to determine factors that might predict the development of end stage renal disease (ESRD) in patients who had ARF after OLT...
  26. ncbi request reprint Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients
    Sander Florman
    Department of Surgery, Tulane School of Medicine, New Orleans, LA, and Department of Surgery, University of Colorado Hospital, Denver, CO, USA
    Transplantation 83:1639-42. 2007
    ..Liver transplant recipients can be converted from twice-a-day TAC to once-daily XL and maintained for at least 2 years postconversion with neither unique efficacy nor safety concerns...
  27. ncbi request reprint Intestinal transplantation before and after the introduction of sirolimus
    Thomas M Fishbein
    Recanati Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY, USA
    Transplantation 73:1538-42. 2002
    ..In June 2000, we began using sirolimus, an immunosuppression agent with proven efficacy in kidney transplantation. We reviewed results among intestinal transplant recipients before and after the introduction of sirolimus...
  28. ncbi request reprint Recurrent portal hypertension after composite liver/small bowel transplantation
    Thomas M Fishbein
    Recanati Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, NY, USA
    Liver Transpl 8:639-42. 2002
    ..Recurrent portal hypertension is challenging in patients who have had combined liver/small bowel transplantation. Surgeons performing intestinal transplantation need to be increasingly aware of these possible late complications...
  29. ncbi request reprint Decision making in intestinal transplantation
    Sander Florman
    Tulane Center for Abdominal Transplantation, New Orleans, LA, USA
    Prog Transplant 15:65-8. 2005
    ..In addition, performing venous drainage of the isolated graft is potentially complex. We discuss the significant advances in surgical and medical decision making in the evaluation and management of patients with intestinal failure...
  30. ncbi request reprint Venous hemodynamics in living donor right lobe liver transplantation
    Gabriel E Gondolesi
    The Recanati Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
    Liver Transpl 8:809-13. 2002
    ..Evaluation of hepatic and portal venous flow is a relatively easy skill to acquire. Intraoperative ultrasound may enable the surgeon to predict graft dysfunction and possibly, may be used to implement pre-emptive therapies...
  31. ncbi request reprint End-to-end portocaval shunt for venous drainage of the native foregut in combined liver-intestinal transplantation
    Gabriel E Gondolesi
    Recanati Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029 6547, USA
    Pediatr Transplant 10:98-100. 2006
    ..This is the first description of this technique that is relatively simple to perform, creating a large vascular conduit with high flow rates and theoretically less turbulence compared with the end-to-side shunt...
  32. ncbi request reprint Noncomposite simultaneous liver and intestinal transplantation
    Thomas Fishbein
    The Recanati Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, NY, USA
    Transplantation 75:564-5. 2003
    ..We discuss the technical aspects of the case and the benefit of such an approach...
  33. ncbi request reprint Transplantation of adult recipients by single cadaveric kidneys from pediatric donors weighing < or = 25 kg can be a reliable option
    Ajay K Sharma
    Tulane Center for Abdominal Transplant, Tulane University Health Sciences Center, New Orleans, LA 70112, USA
    Transpl Int 19:67-71. 2006
    ..The incidence of proteinuria may be more frequent, but does not appear to impact graft function. The use of single, as compared with paired, pediatric donor kidneys would allow more patients to be transplanted with equivalent results...
  34. ncbi request reprint Hand-assisted laparoscopic donor nephrectomy: a low rate of complications
    Ajay K Sharma
    Tulane University Health Sciences Center, New Orleans, LA, USA
    Prog Transplant 15:271-5. 2005
    ..Hand-assisted dissection minimizes the use of instruments for intraoperative retraction and handling of periureteric tissue, and may reduce posttransplant complications...
  35. ncbi request reprint Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor
    Charles Miller
    Recanati Miller Transplantation Institute, New York, NY, USA
    Liver Transpl 10:1315-9. 2004
    ..In conclusion, herein we present the facts and discuss this extraordinary example of florid clostridial infection and toxin-mediated shock. It was completely unexpected and probably unpreventable, and its cause was almost inconceivable...